Headlines
News + Announcements
Cancer Research News
Quicker reviews, designated funding is speeding COVID-19 research efforts at UF Health
Amid the worst public health emergency in a lifetime, UF Health leaders have taken steps to speed novel coronavirus research, recognizing the urgent need to provide answers and options to the communities they serve. There are two key components of this effort: IRB retooled its approval process for coronavirus trials, and the UF Clinical and Translational Science Institute, or CTSI, set up a $2 million pilot research fund for scientists with translational projects that can be rapidly mobilized.
Read more about how Cancer Center members David Nelson, M.D., Duane Mitchell, M.D., Ph.D., and Elias Sayour, M.D., Ph.D., are helping in the fight against COVID-19.
UF researchers shine light on dearth of research on how anti-cancer drugs impact aquatic ecosystems
A group of graduate students working on a class project at the University of Florida developed a critical review of what’s known — and unknown — about the effects of certain cancer drugs on aquatic ecosystems. Their conclusion: Studies are lacking that characterize these impacts, and more research is needed to inform future regulations. READ MORE
Women Experience More Side Effects from Pelvic Radiation than Realized
“There are some symptoms that patients are just not going to bring up easily in discussions with their doctors,” said Anamaria Yeung, M.D., of the University of Florida, who led the study. “And in that case, the clinician is going to assume that they don’t have those symptoms.” READ MORE
Dr. Chengguo Xing’s kava clinical study makes the cover of Cancer Prevention Research
Kava’s reputation in preventing cancer just received a boost from the American Association for Cancer Research. The May cover of the organization’s flagship journal, Cancer Prevention Research, featured a clinical study on kava led by Chengguo “Chris” Xing, Ph.D., a professor of medicinal chemistry and the Frank A. Duckworth Eminent Scholar Chair in the UF College of Pharmacy and a member of the UF Health Cancer Center. READ MORE
Announcements
Register: Healthcare worker exposure response & outcomes (HERO) initiative
UF Health is participating in a new research program to understand the effect of COVID-19 on health care workers. The Healthcare Worker Exposure and Outcomes, or HERO, initiative has two parts — a registry and a clinical trial.
The HERO program is a special opportunity to learn how COVID-19 affects health care workers and to potentially study hydroxychloroquine’s effectiveness as a preventive measure, said Elizabeth A. Shenkman, Ph.D., a professor and chair of the UF College of Medicine’s department of health outcomes and biomedical informatics. She is also the principal investigator for the OneFlorida Clinical Research Consortium, which includes the HERO sites in Florida.
To read more about UF Health’s participation in the HERO program, click here.
UF Health MedEdCast
The official podcast of UF Health provides engaging insight on today’s trending health care topics. Earn CME credits while learning about clinical issues and research advances from experts at UF Health Shands Hospital, one of the nation’s top academic health centers.
Listen to the most recent cancer-related podcasts:
- “Third Space Endoscopy and Advanced Endoscopic Resection Techniques in the Gastrointestinal Tract” with Dennis Yang, M.D.
- “PARP Inhibitors in Ovarian Cancer” with Martina Murphy, M.D.
- “Robotic Urologic Surgery Program” with Li-Ming Su, M.D.
